Literature DB >> 18751940

Mechanical circulatory support for fulminant myocarditis.

Akira Sezai1, Mitsumasa Hata, Tetsuya Niino, Masataka Yoda, Tadateru Takayama, Satoshi Saito, Mamoru Ayusawa, Kazutomo Minami.   

Abstract

PURPOSE: Fulminant myocarditis is potentially fatal because it progresses rapidly into cardiogenic shock; thus, immediate and appropriate treatment is essential. Mechanical circulatory support (MCS) is an important part of treatment for fulminant myocarditis. We review our experience of treating fulminant myocarditis with MCS.
METHODS: We used MCS with veno-arterial bypass (VAB) to treat seven patients with fulminant myocarditis. Five of these patients were younger than 18 years old. The mean time from arriving at our institution to the initiation of MCS was 15.9 +/- 22.6 h. MCS was initiated within 18 h in six patients.
RESULTS: The mean assist time of MCS was 70.9 +/- 35.0 h and six patients were weaned successfully (weaning rate: 85.7%). The remaining patient required support with VAB for 132 h, and a left ventricular assist device was applied. All seven patients were weaned off MCS and discharged.
CONCLUSIONS: Since severe and rapid hemodynamic compromise is typical of fulminant myocarditis, an immediate decision must be made about whether to initiate MCS. We attribute the excellent results and favorable long-term prognosis of our patients to the early initiation of MCS.

Entities:  

Mesh:

Year:  2008        PMID: 18751940     DOI: 10.1007/s00595-007-3724-0

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  12 in total

1.  National survey of fulminant myocarditis in Japan: therapeutic guidelines and long-term prognosis of using percutaneous cardiopulmonary support for fulminant myocarditis (special report from a scientific committee).

Authors:  Naoyoshi Aoyama; Tohru Izumi; Katsuhiko Hiramori; Mitsuaki Isobe; Masatoshi Kawana; Michiaki Hiroe; Hitoshi Hishida; Yasushi Kitaura; Tsutomu Imaizumi
Journal:  Circ J       Date:  2002-02       Impact factor: 2.993

2.  Experience and result of extracorporeal membrane oxygenation in treating fulminant myocarditis with shock: what mechanical support should be considered first?

Authors:  Yih-Sharng Chen; Hsi-Yu Yu; Shu-Chien Huang; Kaung-Ming Chiu; Tzu-Yu Lin; Lin-Ping Lai; Fang-Yue Lin; Shoei-Shan Wang; Shu-Hsun Chu; Wen-Je Ko
Journal:  J Heart Lung Transplant       Date:  2005-01       Impact factor: 10.247

3.  Mechanical ventricular circulatory support in children; Bad Oeynhausen experience.

Authors:  Kazutomo Minami; Edzard von Knyphausen; Ryusuke Suzuki; Ute Blanz; Latif Arusoglu; Michael Morshuis; Aly El-Banayosy; Reiner Körfer
Journal:  Ann Thorac Cardiovasc Surg       Date:  2005-10       Impact factor: 1.520

4.  Five-year follow-up of neonates with reconstructed right common carotid arteries after extracorporeal membrane oxygenation.

Authors:  S A Desai; C Stanley; M Gringlas; D A Merton; P J Wolfson; L Needleman; L J Graziani; S Baumgart
Journal:  J Pediatr       Date:  1999-04       Impact factor: 4.406

5.  Morbidity and outcome after mechanical ventricular support using Thoratec, Novacor, and HeartMate for bridging to heart transplantation.

Authors:  K Minami; A El-Banayosy; A Sezai; L Arusoglu; P Sarnowsky; O Fey; R Koerfer
Journal:  Artif Organs       Date:  2000-06       Impact factor: 3.094

6.  A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators.

Authors:  J W Mason; J B O'Connell; A Herskowitz; N R Rose; B M McManus; M E Billingham; T E Moon
Journal:  N Engl J Med       Date:  1995-08-03       Impact factor: 91.245

7.  Long-term prognosis of fulminant myocarditis rescued by percutaneous cardiopulmonary support device.

Authors:  Yasuhiro Maejima; Takanori Yasu; Norifumi Kubo; Koji Kawahito; Nobuhiro Omura; Takaaki Katsuki; Yoshiaki Tsukamoto; Yoshitaka Sugawara; Shigemasa Hashimoto; Yoshio Tsuruya; Taishi Hirahara; Yosuke Takagi; Nobuhiko Kobayashi; Hiroshi Funayama; Nahoko Ikeda; Takeshi Ishida; Mikihisa Fujii; Takashi Ino; Muneyasu Saito
Journal:  Circ J       Date:  2004-09       Impact factor: 2.993

8.  Circulatory support for fulminant myocarditis: consideration for implantation, weaning and explantation.

Authors:  Pascal Leprince; Alain Combes; Nicolas Bonnet; Alexandre Ouattara; Charles Edouard Luyt; Pierre Theodore; Philippe Léger; Alain Pavie
Journal:  Eur J Cardiothorac Surg       Date:  2003-09       Impact factor: 4.191

9.  Acute fulminant myocarditis in children and adolescents: the role of mechanical circulatory assist.

Authors:  Nils Reiss; Aly El-Banayosy; Latif Arusoglu; Ute Blanz; Andreas Bairaktaris; Reiner Koerfer
Journal:  ASAIO J       Date:  2006 Mar-Apr       Impact factor: 2.872

10.  Clinicopathologic description of myocarditis.

Authors:  E B Lieberman; G M Hutchins; A Herskowitz; N R Rose; K L Baughman
Journal:  J Am Coll Cardiol       Date:  1991-12       Impact factor: 24.094

View more
  2 in total

Review 1.  The Diagnostic and Clinical Approach to Pediatric Myocarditis: A Review of the Current Literature.

Authors:  Ramush Bejiqi; Ragip Retkoceri; Arlinda Maloku; Aferdita Mustafa; Hana Bejiqi; Rinor Bejiqi
Journal:  Open Access Maced J Med Sci       Date:  2019-01-04

2.  Clinical determinants of successful weaning from extracorporeal membrane oxygenation in patients with fulminant myocarditis.

Authors:  Manabu Matsumoto; Yasuhide Asaumi; Yuichi Nakamura; Takeshi Nakatani; Toshiyuki Nagai; Tomoaki Kanaya; Shoji Kawakami; Satoshi Honda; Yu Kataoka; Seiko Nakajima; Osamu Seguchi; Masanobu Yanase; Kunihiro Nishimura; Yoshihiro Miyamoto; Kengo Kusano; Toshihisa Anzai; Teruo Noguchi; Tomoyuki Fujita; Junjiro Kobayashi; Hatsue Ishibashi-Ueda; Hiroaki Shimokawa; Satoshi Yasuda
Journal:  ESC Heart Fail       Date:  2018-05-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.